High levels of extracellular matrix metalloproteinase inducer are expressed in lymphangioleiomyomatosis

Nao Odajima, Tomoko Betsuyaku, Takayuki Yoshida, Takeshi Hosokawa, Masaharu Nishimura

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Pulmonary lymphangioleiomyomatosis is pathologically characterized by the proliferation of abnormal smooth muscle-like cells (lymphangioleiomyomatosis cells) that synthesize excess matrix metalloproteinases. Extracellular matrix metalloproteinase inducer is minimally expressed in the healthy lung, but is up-regulated in various lung injuries that are apparently associated with matrix metalloproteinases. We therefore immunohistochemically stained extracellular matrix metalloproteinase inducer in lymphangioleiomyomatosis cells and measured extracellular matrix metalloproteinase inducer in bronchoalveolar lavage fluid using an enzyme-linked immunosorbent assay. We also quantified extracellular matrix metalloproteinase inducer messenger RNA expression in the lung using quantitative reverse transcriptase-polymerase chain reaction. Intense staining for extracellular matrix metalloproteinase inducer in lymphangioleiomyomatosis cells indicated high immunoreactivity. Dual immunofluorescence studies revealed diffuse colocalization between extracellular matrix metalloproteinase inducer and α smooth muscle actin, matrix metalloproteinase-2, or matrix metalloproteinase-9. Although levels of extracellular matrix metalloproteinase inducer messenger RNA did not differ in whole lung homogenates from patients with lymphangioleiomyomatosis and healthy controls (1.7 ± 0.1 versus 1.5 ± 0.2 SE, not significant; both n = 4), lymphangioleiomyomatosis nodules retrieved by laser capture microdissection expressed 5.1 (±1.0 SE)-fold higher levels of extracellular matrix metalloproteinase inducer messenger RNA than lung homogenates (P = .0077, n = 4). Levels of extracellular matrix metalloproteinase inducer were significantly elevated in bronchoalveolar lavage fluid from lymphangioleiomyomatosis patients compared with controls (82.7 ± 19.5 versus 38.6 ± 9.0 SE pg/mL, P = .0497; n = 8 and 9, respectively). Increased levels of extracellular matrix metalloproteinase inducer colocalized with increased matrix metalloproteinases in lymphangioleiomyomatosis cells indicate that it potentially functions in pulmonary lymphangioleiomyomatosis.

Original languageEnglish
Pages (from-to)935-943
Number of pages9
JournalHuman Pathology
Volume41
Issue number7
DOIs
Publication statusPublished - 2010 Jul
Externally publishedYes

Fingerprint

CD147 Antigens
Lymphangioleiomyomatosis
Lung
Matrix Metalloproteinases
Bronchoalveolar Lavage Fluid
Messenger RNA
Laser Capture Microdissection
Matrix Metalloproteinase 2
Matrix Metalloproteinase 9
Lung Injury
Reverse Transcriptase Polymerase Chain Reaction
Smooth Muscle Myocytes
Fluorescent Antibody Technique
Smooth Muscle
Actins

Keywords

  • Bronchoalveolar lavage
  • Immunohistochemistry
  • Laser capture microdissection

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

High levels of extracellular matrix metalloproteinase inducer are expressed in lymphangioleiomyomatosis. / Odajima, Nao; Betsuyaku, Tomoko; Yoshida, Takayuki; Hosokawa, Takeshi; Nishimura, Masaharu.

In: Human Pathology, Vol. 41, No. 7, 07.2010, p. 935-943.

Research output: Contribution to journalArticle

Odajima, Nao ; Betsuyaku, Tomoko ; Yoshida, Takayuki ; Hosokawa, Takeshi ; Nishimura, Masaharu. / High levels of extracellular matrix metalloproteinase inducer are expressed in lymphangioleiomyomatosis. In: Human Pathology. 2010 ; Vol. 41, No. 7. pp. 935-943.
@article{cc94e8af6f624261a26642cb90090fca,
title = "High levels of extracellular matrix metalloproteinase inducer are expressed in lymphangioleiomyomatosis",
abstract = "Pulmonary lymphangioleiomyomatosis is pathologically characterized by the proliferation of abnormal smooth muscle-like cells (lymphangioleiomyomatosis cells) that synthesize excess matrix metalloproteinases. Extracellular matrix metalloproteinase inducer is minimally expressed in the healthy lung, but is up-regulated in various lung injuries that are apparently associated with matrix metalloproteinases. We therefore immunohistochemically stained extracellular matrix metalloproteinase inducer in lymphangioleiomyomatosis cells and measured extracellular matrix metalloproteinase inducer in bronchoalveolar lavage fluid using an enzyme-linked immunosorbent assay. We also quantified extracellular matrix metalloproteinase inducer messenger RNA expression in the lung using quantitative reverse transcriptase-polymerase chain reaction. Intense staining for extracellular matrix metalloproteinase inducer in lymphangioleiomyomatosis cells indicated high immunoreactivity. Dual immunofluorescence studies revealed diffuse colocalization between extracellular matrix metalloproteinase inducer and α smooth muscle actin, matrix metalloproteinase-2, or matrix metalloproteinase-9. Although levels of extracellular matrix metalloproteinase inducer messenger RNA did not differ in whole lung homogenates from patients with lymphangioleiomyomatosis and healthy controls (1.7 ± 0.1 versus 1.5 ± 0.2 SE, not significant; both n = 4), lymphangioleiomyomatosis nodules retrieved by laser capture microdissection expressed 5.1 (±1.0 SE)-fold higher levels of extracellular matrix metalloproteinase inducer messenger RNA than lung homogenates (P = .0077, n = 4). Levels of extracellular matrix metalloproteinase inducer were significantly elevated in bronchoalveolar lavage fluid from lymphangioleiomyomatosis patients compared with controls (82.7 ± 19.5 versus 38.6 ± 9.0 SE pg/mL, P = .0497; n = 8 and 9, respectively). Increased levels of extracellular matrix metalloproteinase inducer colocalized with increased matrix metalloproteinases in lymphangioleiomyomatosis cells indicate that it potentially functions in pulmonary lymphangioleiomyomatosis.",
keywords = "Bronchoalveolar lavage, Immunohistochemistry, Laser capture microdissection",
author = "Nao Odajima and Tomoko Betsuyaku and Takayuki Yoshida and Takeshi Hosokawa and Masaharu Nishimura",
year = "2010",
month = "7",
doi = "10.1016/j.humpath.2009.12.009",
language = "English",
volume = "41",
pages = "935--943",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - High levels of extracellular matrix metalloproteinase inducer are expressed in lymphangioleiomyomatosis

AU - Odajima, Nao

AU - Betsuyaku, Tomoko

AU - Yoshida, Takayuki

AU - Hosokawa, Takeshi

AU - Nishimura, Masaharu

PY - 2010/7

Y1 - 2010/7

N2 - Pulmonary lymphangioleiomyomatosis is pathologically characterized by the proliferation of abnormal smooth muscle-like cells (lymphangioleiomyomatosis cells) that synthesize excess matrix metalloproteinases. Extracellular matrix metalloproteinase inducer is minimally expressed in the healthy lung, but is up-regulated in various lung injuries that are apparently associated with matrix metalloproteinases. We therefore immunohistochemically stained extracellular matrix metalloproteinase inducer in lymphangioleiomyomatosis cells and measured extracellular matrix metalloproteinase inducer in bronchoalveolar lavage fluid using an enzyme-linked immunosorbent assay. We also quantified extracellular matrix metalloproteinase inducer messenger RNA expression in the lung using quantitative reverse transcriptase-polymerase chain reaction. Intense staining for extracellular matrix metalloproteinase inducer in lymphangioleiomyomatosis cells indicated high immunoreactivity. Dual immunofluorescence studies revealed diffuse colocalization between extracellular matrix metalloproteinase inducer and α smooth muscle actin, matrix metalloproteinase-2, or matrix metalloproteinase-9. Although levels of extracellular matrix metalloproteinase inducer messenger RNA did not differ in whole lung homogenates from patients with lymphangioleiomyomatosis and healthy controls (1.7 ± 0.1 versus 1.5 ± 0.2 SE, not significant; both n = 4), lymphangioleiomyomatosis nodules retrieved by laser capture microdissection expressed 5.1 (±1.0 SE)-fold higher levels of extracellular matrix metalloproteinase inducer messenger RNA than lung homogenates (P = .0077, n = 4). Levels of extracellular matrix metalloproteinase inducer were significantly elevated in bronchoalveolar lavage fluid from lymphangioleiomyomatosis patients compared with controls (82.7 ± 19.5 versus 38.6 ± 9.0 SE pg/mL, P = .0497; n = 8 and 9, respectively). Increased levels of extracellular matrix metalloproteinase inducer colocalized with increased matrix metalloproteinases in lymphangioleiomyomatosis cells indicate that it potentially functions in pulmonary lymphangioleiomyomatosis.

AB - Pulmonary lymphangioleiomyomatosis is pathologically characterized by the proliferation of abnormal smooth muscle-like cells (lymphangioleiomyomatosis cells) that synthesize excess matrix metalloproteinases. Extracellular matrix metalloproteinase inducer is minimally expressed in the healthy lung, but is up-regulated in various lung injuries that are apparently associated with matrix metalloproteinases. We therefore immunohistochemically stained extracellular matrix metalloproteinase inducer in lymphangioleiomyomatosis cells and measured extracellular matrix metalloproteinase inducer in bronchoalveolar lavage fluid using an enzyme-linked immunosorbent assay. We also quantified extracellular matrix metalloproteinase inducer messenger RNA expression in the lung using quantitative reverse transcriptase-polymerase chain reaction. Intense staining for extracellular matrix metalloproteinase inducer in lymphangioleiomyomatosis cells indicated high immunoreactivity. Dual immunofluorescence studies revealed diffuse colocalization between extracellular matrix metalloproteinase inducer and α smooth muscle actin, matrix metalloproteinase-2, or matrix metalloproteinase-9. Although levels of extracellular matrix metalloproteinase inducer messenger RNA did not differ in whole lung homogenates from patients with lymphangioleiomyomatosis and healthy controls (1.7 ± 0.1 versus 1.5 ± 0.2 SE, not significant; both n = 4), lymphangioleiomyomatosis nodules retrieved by laser capture microdissection expressed 5.1 (±1.0 SE)-fold higher levels of extracellular matrix metalloproteinase inducer messenger RNA than lung homogenates (P = .0077, n = 4). Levels of extracellular matrix metalloproteinase inducer were significantly elevated in bronchoalveolar lavage fluid from lymphangioleiomyomatosis patients compared with controls (82.7 ± 19.5 versus 38.6 ± 9.0 SE pg/mL, P = .0497; n = 8 and 9, respectively). Increased levels of extracellular matrix metalloproteinase inducer colocalized with increased matrix metalloproteinases in lymphangioleiomyomatosis cells indicate that it potentially functions in pulmonary lymphangioleiomyomatosis.

KW - Bronchoalveolar lavage

KW - Immunohistochemistry

KW - Laser capture microdissection

UR - http://www.scopus.com/inward/record.url?scp=77953287374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953287374&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2009.12.009

DO - 10.1016/j.humpath.2009.12.009

M3 - Article

C2 - 20236683

AN - SCOPUS:77953287374

VL - 41

SP - 935

EP - 943

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 7

ER -